Who is sponsoring NCT04487639?

NCT04487639 is sponsored by University Hospital, Clermont-Ferrand.

What drugs are being tested in NCT04487639?

Interventions in NCT04487639: SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics.

What condition does NCT04487639 study?

NCT04487639 studies Sperm Preservation in Oncological Patients, Fertility, Cryopreservation.

Is NCT04487639 still recruiting?

NCT04487639 is currently completed. Last updated 16 February 2024.

Last reviewed 2024-02-16 · How we verify

NCT04487639: FERTICOVID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?

Completed NA Last updated 16 February 2024

What this trial tests

NA trial testing SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics in Sperm Preservation in Oncological Patients in 129 participants. Completed in 31 December 2023.

Timeline

10 July 2020

Primary endpoint
2 July 2021

31 December 2023

Quick facts

Lead sponsor	University Hospital, Clermont-Ferrand
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	129
Start date	10 July 2020
Primary completion	2 July 2021
Estimated completion	31 December 2023
Sites	16 locations across France

Drugs / interventions tested

SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics

Conditions studied

Sperm Preservation in Oncological Patients — all drugs for Sperm Preservation in Oncological Patients →
Fertility — all drugs for Fertility →
Cryopreservation — all drugs for Cryopreservation →

Sponsor

University Hospital, Clermont-Ferrand

Who can join

Adults 18 to 60, male only, with Sperm Preservation in Oncological Patients or Fertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the COVID-19 pandemic, the French Agency of Biomedicine has recommended maintaining fertility preservation for patients requiring immediate oncological treatments exhibiting gonadotoxic effects. However, no study has examined the presence of SARS-CoV-2 in sperm from cancer patients. This study aims therefore to detect the presence of SARS-CoV-2, specifically in the seminal fluid and the spermatozoa fractions of cancer patient semen. The investigators will determine if the virus presence in sperm is associated with its presence in the nasal swabs, COVID symptoms, specific serological profiles and particular oncological pathologies/treatments.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

COVID-19 and Oncofertility: No SARS-CoV-2 in Semen but Inflammation Seems to Affect Sperm Parameters.
Chaput L, Pons-Rejraji H, Chabrolles H, Fiot M, et al · · 2024 · cited 2× · PMID 39648939 · DOI 10.1002/jmv.70070

Verify or expand the search:

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04487639 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
Last refreshed: 16 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04487639.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing